Free Trial Information
BioCentury | May 12, 2017
Financial News

Drug delivery play Lamellar raises L5.8M series C

...On May 5, drug delivery company Lamellar Biomedical Ltd. (Bellshill, U.K.) raised £5.8 million ($7.5 million) in a...
...round led by Invesco Asset Management. Scottish Investment Bank also participated. Lamellar Biomedical Ltd. , Bellshill, U.K. Julian Zhu Lamellar Biomedical Ltd....
Read More
BioCentury | Mar 14, 2016
Company News

Lamellar Biomedical, University of Edinburgh deal

...mucosal surfaces and topical infection.” The partners declined to provide further details or financial terms. Lamellar Biomedical Ltd....
Read More
BioCentury | Aug 3, 2015
Financial News

Lamellar Biomedical completes venture financing

Lamellar Biomedical Ltd. , Bellshil, U.K. Business: Pulmonary, Drug delivery Date completed: 2015-07-24 Type: Venture financing Raised: L2.3 million ($3.6 million) Investors: Invesco; Scottish Investment Bank; Barwell plc; Tri Capital Ltd.; private investors WIR Staff...
Read More
BioCentury | Jun 27, 2011
Clinical News

LMS-611 regulatory update

...to start Phase I testing of the surface active phospholipid for the indication in 1Q12. Lamellar Biomedical Ltd....
Read More
Items per page:
1 - 4 of 4
BioCentury | May 12, 2017
Financial News

Drug delivery play Lamellar raises L5.8M series C

...On May 5, drug delivery company Lamellar Biomedical Ltd. (Bellshill, U.K.) raised £5.8 million ($7.5 million) in a...
...round led by Invesco Asset Management. Scottish Investment Bank also participated. Lamellar Biomedical Ltd. , Bellshill, U.K. Julian Zhu Lamellar Biomedical Ltd....
Read More
BioCentury | Mar 14, 2016
Company News

Lamellar Biomedical, University of Edinburgh deal

...mucosal surfaces and topical infection.” The partners declined to provide further details or financial terms. Lamellar Biomedical Ltd....
Read More
BioCentury | Aug 3, 2015
Financial News

Lamellar Biomedical completes venture financing

Lamellar Biomedical Ltd. , Bellshil, U.K. Business: Pulmonary, Drug delivery Date completed: 2015-07-24 Type: Venture financing Raised: L2.3 million ($3.6 million) Investors: Invesco; Scottish Investment Bank; Barwell plc; Tri Capital Ltd.; private investors WIR Staff...
Read More
BioCentury | Jun 27, 2011
Clinical News

LMS-611 regulatory update

...to start Phase I testing of the surface active phospholipid for the indication in 1Q12. Lamellar Biomedical Ltd....
Read More
Items per page:
1 - 4 of 4